$-0.07 EPS Expected for Paramount Gold Nevada (PZG); Hm Payson & Company Trimmed Teva Pharmaceutical Industries (TEVA) Position By $533,124

September 6, 2017 - By Vivian Currie

Hm Payson & Company decreased Teva Pharmaceutical Industries (TEVA) stake by 22.03% reported in 2016Q4 SEC filing. Hm Payson & Company sold 14,809 shares as Teva Pharmaceutical Industries (TEVA)’s stock declined 15.11%. The Hm Payson & Company holds 52,399 shares with $1.90M value, down from 67,208 last quarter. Teva Pharmaceutical Industries now has $15.91B valuation. The stock rose 0.39% or $0.06 reaching $15.47. About 60,631 shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since September 6, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Analysts expect Paramount Gold Nevada Corp (NYSEMKT:PZG) to report $-0.07 EPS on September, 15.They anticipate $0.25 EPS change or 78.13% from last quarter’s $-0.32 EPS. It closed at $1.75 lastly. It is down 0.63% since September 6, 2016 and is uptrending. It has underperformed by 16.07% the S&P500.

Paramount Gold Nevada Corp. is an exploration-stage mining company. The company has market cap of $31.11 million. The Firm is engaged in the business of acquiring, exploring and developing precious metal projects in the United States. It currently has negative earnings. The Company’s principal Nevada interest, the Sleeper Gold Project, is located in Humboldt County, Nevada.

Among 27 analysts covering Teva Pharma (NYSE:TEVA), 6 have Buy rating, 3 Sell and 18 Hold. Therefore 22% are positive. Teva Pharma has $86 highest and $16 lowest target. $46.37’s average target is 199.74% above currents $15.47 stock price. Teva Pharma had 85 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Buy” rating by Mizuho on Tuesday, May 10. The firm earned “Buy” rating on Tuesday, July 28 by Citigroup. The firm has “Underperform” rating given on Friday, August 4 by RBC Capital Markets. Goldman Sachs maintained the shares of TEVA in report on Monday, August 10 with “Buy” rating. The stock has “Neutral” rating by Credit Suisse on Wednesday, May 4. Maxim Group maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Monday, February 13 with “Hold” rating. The rating was initiated by Cantor Fitzgerald on Friday, June 16 with “Neutral”. The rating was downgraded by Goldman Sachs on Friday, July 15 to “Neutral”. The firm has “Market Perform” rating by Wells Fargo given on Monday, January 9. Morgan Stanley downgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Monday, August 7 to “Underweight” rating.

Hm Payson & Company increased Phillips 66 (NYSE:PSX) stake by 48,513 shares to 286,714 valued at $24.78 million in 2016Q4. It also upped Camden National Corporation (NASDAQ:CAC) stake by 7,738 shares and now owns 42,788 shares. At&T Inc (NYSE:T) was raised too.